Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-037413
Filing Date
2020-06-17
Accepted
2020-06-17 18:58:34
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3856
  Complete submission text file 0001209191-20-037413.txt   5425
Mailing Address 161 WASHINGTON STREET SUITE 500 CONSHOHOCKEN PA 19428
Business Address
George Simeon (Reporting) CIK: 0001595117 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38871 | Film No.: 20970864

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations